Company profile

Medtronic

Engineering the extraordinary in healthcare technology

Surgical AI & Robotics

Company profile

About Medtronic

Medtronic is a global leader in healthcare technology, developing and manufacturing medical devices, therapies, and services that improve patient outcomes across a broad spectrum of medical conditions. Founded in 1949, the company has grown into one of the world's largest medical technology companies, serving healthcare professionals, patients, and health systems in over 150 countries. The company's extensive product portfolio spans multiple therapeutic areas including cardiovascular solutions (cardiac rhythm management, interventional cardiology, cardiac surgery), diabetes management technologies, neurological therapies (deep brain stimulation, pain management, spinal solutions), surgical innovations (surgical robotics, surgical stapling, energy devices, navigation and imaging), and patient monitoring systems. Medtronic's surgical robotics division includes advanced robotic-assisted surgical platforms and the Touch Surgery Ecosystem for surgical education and planning. Medtronic serves diverse customer segments including hospitals and health systems, ambulatory surgery centers, office-based labs, physicians, and direct-to-patient services. The company emphasizes innovation through its research programs, clinical evidence generation, and partnerships with healthcare providers. With a mission to alleviate pain, restore health, and extend life, Medtronic combines engineering expertise with clinical insights to address complex healthcare challenges. The company maintains a strong focus on regulatory compliance, reimbursement support, and comprehensive training and education programs for healthcare professionals through its Medtronic Academy and other educational initiatives.

Company description Medtronic official website

Mission. Alleviate pain, restore health, and extend life.

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Medtronic?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • cardiovascular disease
  • chronic pain
  • diabetes
  • ear nose throat conditions
  • gastrointestinal disorders
  • gynecological conditions
  • neurological disorders
  • obesity
  • orthopedic conditions
  • respiratory conditions
  • spinal conditions
  • urological conditions

Who it serves

  • Ambulatory Surgery Centers
  • Federal Healthcare
  • Health Systems
  • Hospitals
  • Office-Based Labs
  • Patients
  • Physicians

Deployment & integration

Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.

Recorded integration context: Cerner, EHR systems, Epic.

Geographic context

Markets150+ countries globally · Africa · Asia · Australia · Canada · Europe · Latin America · Middle East · New Zealand · United States
Company sourceOfficial website

Company milestones

Platform expansion

Expansion of surgical robotics portfolio, Touch Surgery Ecosystem development, digital health monitoring platforms, MRI-conditional device innovations

Partnerships

Recorded partners

  • Academic medical centers
  • Ambulatory surgery centers
  • Healthcare systems
  • Office-based labs
  • Physician groups

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Cardiac Rhythm & Diagnostics

Advanced cardiac monitoring and rhythm management devices

Device · EmbeddedCompany source

Diabetes Management

Integrated insulin delivery and glucose monitoring systems

Device · EmbeddedCompany source

Hugo™ RAS System

Robotic-assisted surgery platform for multiple surgical specialties

Device · On PremiseCompany source

Hugo™ Robotic-Assisted Surgery (RAS) System

Modular robotic-assisted surgery platform for multiple surgical specialties

Device · On PremiseCompany source

Neurological

Advanced neuromodulation and neurosurgical devices

Device · EmbeddedCompany source

Patient Monitoring

AI-powered patient monitoring and acute care solutions

Platform · HybridCompany source

Spinal & Orthopedic

Comprehensive spinal and orthopedic surgical solutions

Device · On PremiseCompany source

Surgical Energy

Advanced energy devices for surgical tissue management

Device · On PremiseCompany source

Surgical Navigation & Imaging

AI-powered surgical navigation and imaging solutions for precision surgery

Platform · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

A systematic review of acute and long-term outcomes in patients with non-transvenous implantable cardioverter-defibrillators.

Journal of medical economics · Dec 1, 2026

Estimands in Cardiovascular Device Trials: What Are They and Why Do They Matter?

Structural heart : the journal of the Heart Team · Nov 1, 2026

Study on identifying a consistent metric for comparison of fatigue performance of superelastic Nickel Titanium across different geometries and loading conditions.

Journal of the mechanical behavior of biomedical materials · Nov 1, 2026

The Surgeon, the Robot, and the Stapler: Comparison of Stapling Strategies During Robotic Lobectomy.

Innovations (Philadelphia, Pa.) · Oct 17, 2026

Evolution of Tined Leadless Pacemaker Implantation: Patient Selection, Implant Volume, Center Characteristics, and Safety Trends.

Heart rhythm · Oct 16, 2026

Transcarotid Access for Transcatheter Aortic Valve Replacement With the Evolut Self-Expanding Valve: Outcomes from a Real-World Registry.

The Annals of thoracic surgery · Oct 16, 2026

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

Stealth AXiS Cranial clinical application

K253379 · 510k · Mar 26, 2026

Stealth AXiS™ Surgical System with Stealth AXiS™ Spine clinical application

K253381 · 510k · Feb 12, 2026

Aurora EV ICD (DVEA3E4)

P220012/S059 · Pma · Oct 28, 2025

Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I

P980016/S939 · Pma · Oct 28, 2025

O-arm O2 Imaging System

K240465 · 510k · Jun 21, 2024

LINQ II Insertable Cardiac Monitor

K233562 · 510k · Dec 6, 2023

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

No Company-reported outcomes are currently listed.

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Medtronic

Recent articles published on Medtronic's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

Epilepsy Patients Train Their Own AI: Penn Medicine's Breakthrough in Self-Learning Seizure Detection

A first-of-its-kind platform enables patients to improve seizure detection algorithms through smartphone feedback, bypassing the need for expert intervention and transforming passive monitoring into active collaboration.

Read on HAIC

Insulin Injections Get Their First Autonomous AI Dose Adjuster as FDA Clears DreaMed's MODI App

New prescription software brings algorithm-driven insulin optimization to the 85% of diabetes patients who don't use pumps, eliminating the physician approval bottleneck.

Read on HAIC

Edwards Lifesciences Bets Big on AI-Powered Heart Valves With Strategic GE HealthCare Hire

The transcatheter valve therapy leader has tapped a GE HealthCare veteran to build a new digital product engineering group focused on AI-enabled structural heart technologies, signaling a strategic shift toward connected cardiac devices.

Read on HAIC

Medicare Opens Door to Early Heart Valve Intervention as CMS Greenlights TAVR for Symptom-Free Patients

New national coverage determination expands access to transcatheter aortic valve replacement before cardiac damage occurs, reshaping a $7 billion market while requiring evidence generation for asymptomatic population.

Read on HAIC

Pharmaceutical Giant McKesson Hit by Massive Vishing Attack as Hackers Claim 284 Million Patient Records Stolen

Healthcare distribution leader confirms cybersecurity incident after ShinyHunters extortion group allegedly compromised employee credentials through voice phishing to access cloud data warehouses containing sensitive medical information.

Read on HAIC

Medtronic Takes Aim at Intuitive Surgical's Dominance with Real-Time AI Platform for Robotic Surgery

Medical device giant secures FDA clearance for computer vision application that monitors surgical instruments in real time, marking a strategic push into AI-powered surgical robotics.

Read on HAIC

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon